China’s SFDA Lifts Drug License, Bans Principals Over Rabies Vaccine
This article was originally published in PharmAsia News
Executive Summary
China's State FDA has found the general manager of Dalian Jingang-Andi Bio-products responsible for the decision to add nucleic acid to the production of human rabies vaccines to lower production costs. The agency also lifted the drug maker's production license and barred its principals from involvement in the pharmaceutical industry for the next 10 years. SFDA emphasized it has not completed its investigation and could implicate still others in the scandal. Although nucleic acid is used as an adjuvant in anti-viral drugs produced in other countries, China has not approved its use in rabies vaccines. (Click here for more